Microdose Psychedelic Insights, a cutting-edge media company focused on promoting content, financial analysis, and engaging events designed to drive the psychedelics industry into the forefront of modern medicine, announced that it will be hosting the Molecular Masterclass: LSD Conference next week. Microdose is hosting the event, scheduled for Feb. 17, 2022, in partnership with MindBio Therapeutics. The all-virtual conference is designed to offer a scientific deep dive into the dynamic field of LSD microdosing exploring the potential of LSD at the intersection of drug development and safety, clinical care and applications, law and regulation, business and markets, science and research, and history and culture. Presentations during the one-day event include “The History of That ‘Curious Molecule’” by Peter Van der Heyden, chief scientific officer at Psygen Industries, and William Leonard Pickard, former research associate in neurobiology at Harvard Medical School. Event participants can watch the presentation live and even participate in a question-and-answer session afterward. Other discussions include “The Therapeutic Use of LSD in Psychiatry,” “Posology and Tolerance to Regression,” “Safety and Efficacy of Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy,” “LSD Microdosing,” “Effect of Lysergic Acid Diethylamide (LSD) on Learning” and “The Effects of LSD on Creativity.” The event agenda also offers networking opportunities in group settings and one-on-one meetings. MindBio Therapeutics is a clinical-stage, drug-development company researching the medicinal use of psychedelic medicines to treat a range of debilitating mental health conditions.
To attend the event, visit https://nnw.fm/oQNGz
To view the full press release, visit https://nnw.fm/vRf5z
About Microdose Psychedelic Insights
Microdose Psychedelic Insights is a guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, the company distribute and create the most compelling content, financial analysis, engaging events, and ground-breaking education to drive the psychedelics industry to the forefront of modern medicine. For more information about the company, visit www.Microdose.buzz.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
